EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer.
暂无分享,去创建一个
A. Stopeck | A. Forero | D. Yardley | M. Melisko | D. Citrin | T. Davis | M. Yellin | L. Vahdat | M. Saleh | F. Arena | Agustin A. Garcia | R. Loutfi | T. Hawthorne | S. Cruickshank | T. Cigler | E. Crowley | Jennifer M. Green | R. Weaver | R. Bechhold | I. Oliff | Jennifer Green | M. Saleh